“… 4 Economic data such as daily costs, costs per infection, and costs for PN treatment were extracted from published sources for each country and treatment arm (Table 1 ). 4 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 , 43 , 44 , 45 , 46 , 47 The models also included inputs on the clinical outcomes nosocomial infections, HLOS, and mortality. The latter 2 parameters defined the end of the patient pathway, whereas the first reflected only costs.…”